Clinical trial
Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell…
NCT00004230 · Northwestern University, Other · Completed
Key facts
| NCT number | NCT00004230 |
|---|---|
| Title | Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation |
| Official title | Phase III Study of Captopril in Patients Undergoing Autologous Bone Marrow/Stem Cell Transplantation |
| Lead sponsor | Northwestern University, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cancer |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | captopril, cyclophosphamide, autologous bone marrow transplantation, peripheral blood stem cell transplantation, radiation therapy |
| Enrollment | 35 |
| Start date | Oct 1, 1999 |
| Primary completion | Mar 1, 2002 |
| Completion | Mar 1, 2002 |
| First posted | May 3, 2004 |
| Last update posted | Jun 6, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: